1. Ivabradine rescues vascular abnormalities in a mouse model of duchenne muscular dystrophy. (10th June 2022) Authors: Acar, E; Kuruppu Appuhamilage, M; Szabo, PL; Trojanek, S; Abraham, D; Hilber, K; Podesser, BK; Kiss, A Journal: Cardiovascular research Issue: Volume 118(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Tenascin-C provokes cardiac fibrosis and endothelial impairment in Duchenne Muscular Dystrophy. (10th June 2022) Authors: Szabo, P L; Inci, M; Hilber, K; Abraham, D; Trojanek, S; Costantino, S; Paneni, F; Podesser, B K; Kiss, A Journal: Cardiovascular research Issue: Volume 118(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Increased Tenascin-C expression contributes to cardiac dysfunction and fibrosis in Duchenne muscular dystrophy. (3rd October 2022) Authors: Kiss, A; Szabo, P L; Ebner, J; Hilber, K; Abraham, D; Costantino, S; Paneni, F; Nikhanj, A; Kashyap, N; Ouadit, G Y; Podesser, B K Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗